Ocular Oncology News

Women who use taxane chemotherapy agents may be at a higher risk to develop epiphora, optic neuropathy and cystoid macular edema, according to a study.

In patients with class 2 uveal melanoma tumors, predicted metastasis-free survival by a gene expression profile test was shown to be worse than that observed in a cohort study and worse than that reported in the literature.

Aura Biosciences announce positive visual acuity results from a phase 1b/2 trial of its cancer drug AU-011 in patients with choroidal melanoma.

A 73-year-old white woman was referred to the retina service at the New England Eye Center for consideration of pars plana vitrectomy and lensectomy in the right eye for a hypermature cataract and angle-closure glaucoma.

An 81-year-old retired teacher presented to the cornea clinic for right eye redness and irritation that started 2 months prior.

PHILADELPHIA — It is essential for ophthalmologists to look into the eye, flip the lid and remove the lesion completely when assessing and treating orbital tumors, according to a speaker here.

PHILADELPHIA — In this Healio Video Perspective from the Wills Eye Conference, Carol L. Shields, MD, discusses updates in uveal melanoma.

The FDA approved tebentafusp-tebn for the treatment of adults with HLA-A*02:01-positive unresectable or metastatic uveal melanoma.

WAIKOLOA, Hawaii — The landscape of ocular oncology is “rapidly evolving” in a way similar to medical oncology, a speaker said during a presentation here.

A 59-year-old woman presented to Lahey Hospital & Medical Center in June 2021 with a several months’ history of bilateral light sensitivity, intermittent watery eyes and blurred vision.